Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Apr/23/2021 82 20
Methylprednisolone Potential treatment - clinical evidence Used to treat other disease Other treatment Apr/10/2021 35 4
Bamlanivimab Emergency use authorization Experimental Antiviral Apr/05/2021 3 4
Etesevimab Emergency use authorization Experimental Antiviral Apr/01/2021 1 1
Mesenchymal stem cells Potential treatment - clinical evidence Experimental Other treatment Apr/01/2021 11 0
Ivermectin Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/30/2021 17 2
Anakinra  Potential treatment - clinical evidence Used to treat other disease Other treatment Mar/08/2021 15 2
Boceprevir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/01/2021 13 0
Tipranavir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/20/2021 6 1
Micafungin Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/20/2021 1 0